.avif)
Acromegaly
Biomarker testing helps detect excessive growth hormone activity driving acromegaly, which enlarges soft tissues and organs. Measuring insulin-like growth factor 1 (IGF-1) reflects chronic GH exposure and flags disease burden. At Superpower, we test IGF-1 to screen and monitor acromegaly physiology.
Addison’s Disease
Addison’s Disease undermines adrenal hormone production, disrupting fluid balance, blood pressure, and stress response. Biomarker testing clarifies this physiology early. At Superpower, we measure Cortisol (adrenal output), Sodium (mineralocorticoid effect), and Potassium (renal handling) to detect adrenal insufficiency patterns and guide timely evaluation.
Cushing’s Syndrome
Biomarker testing clarifies suspected Cushing’s Syndrome by detecting sustained cortisol excess that disrupts metabolism, blood pressure, and immunity (hypercortisolism). At Superpower, we test Cortisol and DHEAS to assess adrenal drive and distinguish potential sources, giving an early, systems-level view of HPA-axis dysfunction.
GH Deficiency
Biomarker testing clarifies how your growth hormone system functions—shaping energy, body composition, bone, and metabolic health. Low IGF‑1 reflects reduced GH signaling (somatotropic axis) and supports diagnosis. At Superpower, we test for IGF‑1 for GH Deficiency to understand whole‑body growth and repair.
Graves’ Disease
Graves’ Disease accelerates thyroid hormone output, stressing metabolic, cardiovascular, and neurocognitive systems. Biomarker testing clarifies the axis: low TSH with high Free T4 confirms hyperthyroid physiology; TPO and thyroglobulin antibodies (TPO Ab, Tg Ab) map autoimmune activity. At Superpower, we test TSH, Free T4, TPO Ab, and Tg Ab.
Hashimoto’s
Hashimoto’s is an autoimmune thyroid condition where immune antibodies target thyroid proteins, impairing hormone production and metabolic regulation. Biomarker testing clarifies immune activity and gland function. At Superpower, we measure TPO Ab, Tg Ab, TSH, and Free T4 to map disease presence and thyroid reserve.
Hyperprolactinemia
Hyperprolactinemia disrupts the hypothalamic‑pituitary‑gonadal axis, altering fertility, libido, bone turnover, and metabolic balance. Biomarker testing pinpoints hormone excess and its physiological impact. At Superpower, we test Prolactin for Hyperprolactinemia to confirm elevations and assess pituitary signaling, helping contextualize symptoms and systemic risks.
Hyperthyroidism
Hyperthyroidism testing clarifies how fast your metabolism is running by measuring thyroid hormone signals and autoimmunity. At Superpower, we assess TSH ↓, Free T4 Index ↑, T4 Total ↑, T3 Uptake ↑, plus thyroid antibodies (TPO Ab, Tg Ab) to pinpoint overactivity and its autoimmune drivers.
Hypothyroidism
Hypothyroidism slows metabolic control; biomarker testing reveals hormone output and autoimmune causes. At Superpower, we test TSH ↑, Free T4 Index ↓, T4 Total ↓, T3 Uptake ↓, TPO Ab, and Tg Ab to confirm thyroid hormone deficiency and identify Hashimoto’s thyroiditis.
Subclinical Hyperthyroidism
Biomarker testing detects early thyroid overactivity before symptoms. It reveals a quiet mismatch: the pituitary signal is suppressed while circulating hormone remains normal. This pattern—low TSH with normal Free T4 Index—defines subclinical hyperthyroidism. At Superpower, we test for TSH ↓, Free T4 Index N.
Subclinical Hypothyroidism
Early thyroid shifts are silent. Biomarker testing detects pituitary stress before symptoms: TSH rises while circulating hormone remains normal. At Superpower, we test for TSH ↑, Free T4 Index N to confirm subclinical hypothyroidism, revealing early thyroid underactivity that influences energy, metabolism, cardiovascular risk, and reproductive function.
